Ashley Decastro, OTD, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 525 S Chandler Village Dr, Chandler, AZ 85226 Phone: 602-648-5444 Fax: 602-772-3801 |
Mr. Matthew J Roberts, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2040 S Alma School Rd, Suite 1-pmb500, Chandler, AZ 85248 Phone: 602-323-0894 |
Ms. Kristin M Schult, OTR Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 |
Yanet Ybarra, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Rd Ste A106, Chandler, AZ 85224 Phone: 480-855-0474 Fax: 480-907-6855 |
Lara Taggart Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 815 E Warner Rd Ste 106, Chandler, AZ 85225 Phone: 480-963-5800 |
News Archive
With flu season approaching in the United States, new research from an international team of scientists testifies to the importance of timely vaccination
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The study by researchers from Sweden also found that RA patients who smoked in the past did not experience a lower response to these therapies. Results of the 10-year study appear in the January 2011 issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).
Oral antiplatelet therapy Effient has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients undergoing percutaneous coronary intervention fter experiencing heart-related chest pain at rest or non-ST segment elevation myocardial infarction.
› Verified 5 days ago